Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2008 Feb 12:6:8.
doi: 10.1186/1479-5876-6-8.

The Italian Network for Tumor Biotherapy (NIBIT): getting together to push the field forward

Michele Maio  1 , Hugues Jm Nicolay, Paolo Ascierto, Filippo Belardelli, Roberto Camerini, Mario P Colombo, Paola Queirolo, Ruggero Ridolfi, Vincenzo Russo, Lucia Anzalone, Ester Fonsatti, Giorgio Parmiani
Affiliations
Editorial

The Italian Network for Tumor Biotherapy (NIBIT): getting together to push the field forward

Michele Maio et al. J Transl Med. .

Abstract

As for a consolidated tradition, the 5th annual meeting of the Italian Network for Cancer Biotherapy took place in the Certosa of Pontignano, a Tuscan monastery, on September 20-22, 2007. The congress gathered more than 40 Italian leading groups representing academia, biotechnology and pharmaceutical industry. Aim of the meeting was to share new advances in cancer bio-immunotherapy and to promote their swift translation from pre-clinical research to clinical applications. Several topics were covered including: a) molecular and cellular mechanisms of tumor escape; b) therapeutic antibodies and recombinant constructs; c) clinical trials up-date and new programs; d) National Cooperative Networks and their potential interactions; e) old and new times in cancer immunology, an "amarcord". Here, we report the main issues discussed during the meeting.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The Main Cloister of the Certosa of Pontignano (Siena, Italy).
See this image and copyright information in PMC

References

    1. Webb C, Pass H. Translation research: from accurate diagnosis to appropriate treatment. Journal of Translational Medicine. 2004;2:35. doi: 10.1186/1479-5876-2-35. - DOI - PMC - PubMed
    1. Ioannidis J. Materializing research promises: opportunities, priorities and conflicts in translational medicine. Journal of Translational Medicine. 2004;2:5. doi: 10.1186/1479-5876-2-5. - DOI - PMC - PubMed
    1. Parks M, Disis M. Conflicts of interest in translational research. Journal of Translational Medicine. 2004;2:28. doi: 10.1186/1479-5876-2-28. - DOI - PMC - PubMed
    1. Lehmann F, Lacombe D, Therasse P, Eggermont A. Integration of Translational Research in the European Organization for Research and Treatment of Cancer Research (EORTC) Clinical Trial Cooperative Group Mechanisms. Journal of Translational Medicine. 2003;1:2. doi: 10.1186/1479-5876-1-2. - DOI - PMC - PubMed
    1. Marincola E. Why is public science education important? Journal of Translational Medicine. 2006;4:7. doi: 10.1186/1479-5876-4-7. - DOI - PMC - PubMed

Substances